New study aims to spot MS before symptoms start
NCT ID NCT07135752
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at people with radiologically isolated syndrome (RIS) — a pre-symptomatic stage of multiple sclerosis — and compares them to MS patients with normal neurological exams. Researchers will use digital tools, MRI scans, and biological tests to find better ways to track early disease. The goal is to understand if these markers can predict who will develop MS symptoms, potentially leading to earlier monitoring or treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify better ways to monitor early MS and predict who might develop symptoms, potentially guiding earlier treatment decisions.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to immediate clinical changes, and the biomarkers studied may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIOLOGICALLY ISOLATED SYNDROMES; MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
RECRUITINGNice, 06000, France